- Home
- CTNM vs AHL^F Comparison
CTNM vs AHL^F Comparison
Compare CTNM & AHL^F Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNM
- AHL^F
- Stock Information
- Founded
- CTNM 2009
- AHL^F N/A
- Country
- CTNM United States
- AHL^F Bermuda
- Employees
- CTNM N/A
- AHL^F N/A
- Industry
- CTNM
- AHL^F
- Sector
- CTNM
- AHL^F
- Exchange
- CTNM Nasdaq
- AHL^F Nasdaq
- Market Cap
- CTNM 114.1M
- AHL^F N/A
- IPO Year
- CTNM 2024
- AHL^F N/A
- Fundamental
- Price
- CTNM $3.87
- AHL^F N/A
- Analyst Decision
- CTNM Strong Buy
- AHL^F
- Analyst Count
- CTNM 4
- AHL^F 0
- Target Price
- CTNM $23.75
- AHL^F N/A
- AVG Volume (30 Days)
- CTNM 86.8K
- AHL^F N/A
- Earning Date
- CTNM 05-16-2025
- AHL^F N/A
- Dividend Yield
- CTNM N/A
- AHL^F N/A
- EPS Growth
- CTNM N/A
- AHL^F N/A
- EPS
- CTNM N/A
- AHL^F N/A
- Revenue
- CTNM N/A
- AHL^F N/A
- Revenue This Year
- CTNM N/A
- AHL^F N/A
- Revenue Next Year
- CTNM N/A
- AHL^F N/A
- P/E Ratio
- CTNM N/A
- AHL^F N/A
- Revenue Growth
- CTNM N/A
- AHL^F N/A
- 52 Week Low
- CTNM $3.69
- AHL^F N/A
- 52 Week High
- CTNM $22.00
- AHL^F N/A
- Technical
- Relative Strength Index (RSI)
- CTNM N/A
- AHL^F N/A
- Support Level
- CTNM N/A
- AHL^F N/A
- Resistance Level
- CTNM N/A
- AHL^F N/A
- Average True Range (ATR)
- CTNM 0.00
- AHL^F 0.00
- MACD
- CTNM 0.00
- AHL^F 0.00
- Stochastic Oscillator
- CTNM 0.00
- AHL^F 0.00
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.